References
- Dune B. G.M., Salmon S. E. Multiple myeloma, macroglobulinemia and monoclonal gammopathies. Recent advances in hematology, A. V. Hoffbrand, M. C. Brain, J Hirsch. Churchill-Livingstone, Edinburgh 1977; Vol 2: 243–261
- Durie B. G.M. Staging and kinetics of multiple myeloma. Semininars in Oncology 1986; 13: 300–309
- Ong F., Hermans J., Noordijk E. M., Kluin-Nelemans J. C. Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinaemia and multiple myeloma. Annals of Hematology 1995; 70: 19–24
- Kyle R. A., Greipp P. R. Plasma cell dyscrasias: current status. Critical Reviews in Oncology and Hematology 1988; 8: 93–152
- Greipp P. R. Monoclonal gammopathies: new approaches to clinical problems in diagnosis and prognosis. Blood Reviews 1989; 3: 222–236
- Greipp P. R. Advances in the diagnosis and management of myeloma. Seminars in Hematology 1992; 29: 24–45, (suppl 2)
- Lymphoma Tumor Group. Plasma cell disorders. Cancer Treatment Policies. British Columbia Cancer Agency, British ColumbiaCanada 1992; 4–6
- Ong F., Hermans J., Noordijk E. M., De Kieviet W., Wijermans P. W., Seelen P. J., Snijder S., Oostindier M. J., Kluin-Nelemans J. C. Developing a population-based registry for patients with paraproteinemias or multiple myeloma. Journal of Clinical Epidemiology 1997; 50: 909–915
- Ong F., Hermans J., Noordijk E. M., Wijermans P. W., Seelen P. J., De Kieviet W., Gerrits W. B.J., Kluin Ph. M., Kluin-Nelemans J. C. A population-based registry on paraproteinaemia in the Netherlands. British Journal of Haematology 1997; 99: 914–920
- Durie B. G.M., Salmon S. E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842–854